Is Global Longlife Hospital Researc a good stock to invest in?

Global Longlife Hospital Researc can be analyzed on the following key metrics - TTM P/E: 99.79 Sector P/E: 22.38 Dividend Yield: 0% D/E ratio: -

Global Longlife Hospital Researc Share Price

Sector: Healthcare Facilities

Powered by

24.25 -0.69 (-2.77%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 24.25

Today’s High 24.25

52 Week Low 18.30

52 Week High 46.44

Key Metrics

Market Cap (In Cr) 25.47
Beta -
Div. Yield (%) 0
P/B 0.95
TTM P/E 99.79
Sector P/E 22.38
D/E 0
Open Price 24.25
Prev Close 24.94

View All Metrics

Global Longlife Hospital Researc Analysis

Price Analysis

1 Week

-7.27%
3 Months

27.9%
6 Month

-24.22%
YTD

-21.77%
1 Year

-28.25%

Risk Meter

82% Low risk
82% Moderate risk
82% Balanced Risk
82% High risk
82% Extreme risk

Global Longlife Hospital Researc Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
0.58

Selling/ General/ Admin Expenses Total
1.14

Depreciation/ Amortization
0.48

Other Operating Expenses Total
1.34

Total Operating Expense
5.22

Operating Income
-4.64

Net Income Before Taxes
0.1

Net Income
0.2

Diluted Normalized EPS
0.19

Period
2024

Total Revenue
13.51

Selling/ General/ Admin Expenses Total
3.34

Depreciation/ Amortization
1.25

Other Operating Expenses Total
2.02

Total Operating Expense
15.08

Operating Income
-1.56

Net Income Before Taxes
-2.27

Net Income
-2.19

Diluted Normalized EPS
-2.08

Period
2023

Total Revenue
23.5

Selling/ General/ Admin Expenses Total
3.63

Depreciation/ Amortization
1.17

Other Operating Expenses Total
2.35

Total Operating Expense
20.63

Operating Income
2.87

Net Income Before Taxes
2.71

Net Income
1.83

Diluted Normalized EPS
1.79

Period
2022

Total Revenue
32.82

Selling/ General/ Admin Expenses Total
4.06

Depreciation/ Amortization
1.14

Other Operating Expenses Total
3.42

Total Operating Expense
25.87

Operating Income
6.94

Net Income Before Taxes
5.71

Net Income
3.57

Diluted Normalized EPS
5.16

Period
2021

Total Revenue
32.7

Selling/ General/ Admin Expenses Total
4.38

Depreciation/ Amortization
1.31

Other Operating Expenses Total
14.25

Total Operating Expense
28.52

Operating Income
4.18

Net Income Before Taxes
1.82

Net Income
1.04

Diluted Normalized EPS
1.48

Period
2020

Total Revenue
33.54

Selling/ General/ Admin Expenses Total
4.14

Depreciation/ Amortization
1.55

Other Operating Expenses Total
21.56

Total Operating Expense
32.31

Operating Income
1.23

Net Income Before Taxes
-1.06

Net Income
-0.86

Diluted Normalized EPS
-1.23

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Global Longlife Hospital Researc Technical

Moving Average SMA

5 Day24.95
10 Day26.34
20 Day28.47

50 Day25.53
100 Day27.02
300 Day29.8

Global Longlife Hospital Researc Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Tejnaksh Healthcare
19.2
0.27
1.43
29.5
18.79
39

Samsrita Labs
20.71
-0.42
-1.99
32.36
12.19
30.67

Global Longlife Hospital Researc
24.25
-0.69
-2.77
46.44
18.3
25.47

Chennai Meenakshi Multi Hospital
34
0.9
2.72
59.9
28.34
25.47

Family Care Hospitals
4.43
0.07
1.61
9.5
3.4
23.93

Global Longlife Hospital Researc Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

28-Apr-25
Audited Results

28-Oct-24
Half Yearly Results

20-May-24
Audited Results

11-Nov-23
Half Yearly Results

30-May-23
Audited Results

27-May-23
Audited Results

12-Nov-22
Half Yearly Results

30-May-22
Audited Results

Meeting Date
Announced on
Purpose

27-Sept-24
05-Sept-24
AGM

26-Sept-23
23-Aug-23
AGM

View All

Company Profile

ABOUT Global Longlife Hospital Researc

Industry Healthcare Facilities
ISIN INE0J2K01014
BSE Code 543520

Global Longlife Hospital and Research Limited is an India-based company. The Company is a multi-specialty tertiary care hospital. The Company offers medical services across oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, GI medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include CVTS, joint replacement & ortho, general surgery, onco surgery, GI surgery, neurosurgery, ENT, plastic surgery, trauma center, urology, laparoscopic surgery, gynecology, and more. Its radiology services include mammography, CT scan, x-ray, ultrasound, endoscopy, sonography. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy. It has around 110 beds for medical and surgical specialties.

MANAGEMENT

Hetal Thakkar Chief Financial Officer, Executive Director
Tanvi Solanki Compliance Officer, Company Secretary
Dhruv Jani Managing Director, Executive Director

GLOBAL LONGLIFE HOSPITAL RESEARC SUMMARY

Global Longlife Hospital Researc is trading 2.77% lower at Rs 24.25 as compared to its last closing price. Global Longlife Hospital Researc has been trading in the price range of 24.25 & 24.25. Global Longlife Hospital Researc has given -21.77% in this year & -7.27% in the last 5 days.

Global Longlife Hospital Researc has TTM P/E ratio 99.79 as compared to the sector P/E of 22.38.

The company posted a net profit of -1.04 Crores in its last quarter.

Listed peers of Global Longlife Hospital Researc include Tejnaksh Healthcare (1.43%), Samsrita Labs (-1.99%), Global Longlife Hospital Researc (-2.77%) etc.

Global Longlife Hospital Researc has a 54.29% promoter holding & 45.71% public holding.

FAQs about Global Longlife Hospital Researc

Global Longlife Hospital Researc is trading at 24.25 as on 27 Jun, 2025 2:52:42 PM. This is -2.77% lower as compared to its previous closing price of 24.94

The market capitalization of Global Longlife Hospital Researc is 25.47 Cr as on 27 Jun, 2025 2:52:42 PM.

The 52 wk high for Global Longlife Hospital Researc is 46.44 whereas the 52 wk low is 18.30

Global Longlife Hospital Researc can be analyzed on the following key metrics -

TTM P/E: 99.79
Sector P/E: 22.38
Dividend Yield: 0%
D/E ratio: -

Global Longlife Hospital Researc reported a net profit of 0.2 Cr in 2025.

Global Longlife Hospital Researc Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Global Longlife Hospital Researc Share Price

Price Range

Key Metrics

Global Longlife Hospital Researc Analysis

Global Longlife Hospital Researc Financials

Forecast

Forecast

Forecast

Global Longlife Hospital Researc Technical

Global Longlife Hospital Researc Peers

Global Longlife Hospital Researc Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Global Longlife Hospital Researc

MANAGEMENT

GLOBAL LONGLIFE HOSPITAL RESEARC SUMMARY

FAQs about Global Longlife Hospital Researc

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue